" the FDA have essentially given us a ticket to approval if can replicate results"
That may not be entirely true. There are many different methods of evaluating pain in patients and in the last trial it wasn't as robust as it could have been. While the end points may have been accepted, the methodology may not have been discussed or approved by the FDA.
- Forums
- ASX - By Stock
- Ann: 36-Month Results of Phase 3 Trial in Chronic Low Back Pain
" the FDA have essentially given us a ticket to approval if can...
-
- There are more pages in this discussion • 179 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.45 |
Change
0.065(4.69%) |
Mkt cap ! $1.655B |
Open | High | Low | Value | Volume |
$1.39 | $1.50 | $1.38 | $7.016M | 4.856M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10425 | $1.44 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.45 | 44243 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10425 | 1.440 |
2 | 9000 | 1.435 |
4 | 62190 | 1.430 |
1 | 473 | 1.425 |
1 | 5000 | 1.420 |
Price($) | Vol. | No. |
---|---|---|
1.450 | 16999 | 2 |
1.455 | 17000 | 1 |
1.465 | 24896 | 3 |
1.470 | 112738 | 6 |
1.475 | 1800 | 1 |
Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |